Drugs / H7N9 Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03369808 | Dec 2017 → Aug 2018 | avian influenza | Shanghai Institute Of Biological Products | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT03755427 | Nov 2018 → Jan 2019 | avian influenza | Shanghai Institute Of Biological Products | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H7N9 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03369808 ↗ |
| Modality | Vaccine | “The vaccine was a inactivated, whole virion preparation of the influenza A/Shanghai/2/2013(H7N9) virus” NCT03369808 ↗ |